Press Releases

Management to host conference call on Monday, August 11, 2025, at 4:30 PM ET

Prize AI Technologies launched a $PRIZE token presale, raising $100K+ in the first week and targeting the $400B arcade/casino market. The platform integrates AI analytics with blockchain rewards through a consumer app and an operator dashboard. Stage 1 tokens are priced at $0.01 and have 33% APR staking yields.

TORONTO, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today reported financial results for the three and nine months ended June 30, 2025 and provided an update on its business.

Singapore, Singapore, Aug. 08, 2025 (GLOBE NEWSWIRE) -- The JinGangShan Asia-Pacific General Association today announced the official launch of two landmark initiatives valued at a combined SGD $43 billion, with strategic developments on Bintan Island, Indonesia, and Penang Island, Malaysia. These flagship projects—the ultra-secure Bintan Citadel and the bi-national Life Memorial Services Park—mark a significant milestone in the Association’s mission to create the world’s foremost sanctuary for safeguarding human cultural heritage and wealth for generations to come.

SPRINGFIELD, Mo., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Paul Mueller Company (OTC: MUEL) today announced that its Board of Directors has declared a cash dividend of 30 cents ($0.30) per share on its outstanding common stock. The action was taken on August 8, 2025, at a regular meeting of the Board of Directors. The dividend of 30 cents ($0.30) per share is payable on September 26, 2025, to shareholders of record on August 26, 2025.

CAMBRIDGE, Mass., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.^® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that the company granted non-statutory stock options to new employees. Fulcrum granted stock options to purchase shares of the company’s common stock pursuant to the company’s 2022 Inducement Stock Incentive Plan, as amended, or the plan, as an inducement material to the new employees entering into employment with Fulcrum in accordance with Nasdaq Listing Rule 5635(c)(4).

Strategic results-driven leader with deep CPG experience and connectivity in retail to succeed Dean General, who will remain at Advantage in newly created role